Pyrazoles

US10155727B2 · kind B2 · utility

Assignee

• Janssen Pharmaceuticals, Inc. · BE

Inventors

• Rudolf Schindler · Dresden, DE
• Hans-Joachim Lankau · Weinböhla, DE
• Norbert Höfgen · Radeberg, DE
• Christian Grunwald · Dresden, DE
• Ute Egerland · Radebeul, DE
• Barbara Langen · Radebeul, DE
• Rita Dost · Dresden, DE
• Thorsten Hage · Dürnhart, DE
• Simon Edward Ward · Peacehaven, GB

Key dates

• Filing date: Aug 14, 2015
• Grant date: Dec 18, 2018
• Expiry date: Aug 14, 2035

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D403/06
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to pyrazole derivatives which are NMDA NR2B receptor inhibitors, useful in treating central nervous system diseases.